Arch Venture Corp »

Singular Genomics Systems In shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Singular Genomics Systems In (OMIC) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 127k 8.45

More positions owned by Arch Venture Corp

Beam Therapeutics (BEAM)
Rapport Therapeutics (RAPP)
Erasca (ERAS)
Verve Therapeutics (VERV)
Gossamer Bio (GOSS)
Q32 Bio (QTTB)
Unity Biotechnology Com New (UBX)
Singular Genomics Systems Com New (OMIC)
Cero Therapeutics Holdings Class A Com (CERO)

View all positions for Arch Venture Corp

Top funds holding Singular Genomics Systems In

Tang Capital Management
Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Vanguard Group
Perceptive Advisors
BlackRock
Geode Capital Management
HighTower Advisors
BlackRock
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In